4
Changes in Ownership
Adaptive Biotechnologies Corp Filed Acc 0001062993-25-004800
Director sold 15,664 shares at $7.94 ($124,372)
- Director acquired 15,394 shares (grant or award)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
GRIFFIN MICHELLE RENEE · Director
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2025-03-04 | Grant or award : show line 1 in the form 10b5-1 | +15,394 | 67,349 | D | ||
| 2025-03-06 | Sale : show line 2 in the form 10b5-1 | −15,664 | $7.94 | $124,372 | 51,685 | D |
| Open-market sales · 15,664 sh · avg $7.94 · $124,372 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2025-03-04 | Grant or award : show line 3 in the form 10b5-1 Stock Option (right to buy) | +23,726 | 23,726 | D |
Loading xslF345X05/form4.xml…